Andere Sprachen BioPorto A/S

Aktien

Verzögert Nasdaq Copenhagen Andere Börsenplätze 09:45:42 01.05.2024			% 5 Tage	% 1. Jan.
1.3 ^DKK	+0.31%		+5.69%	-37.80%

10.04.	BioPorto ernennt neue Leiterin der Rechtsabteilung	MT
10.04.	Bioporto A/S ernennt Gry Louise Husby Larsen zum Chief Legal Officer und Mitglied des Executive Management Teams mit Wirkung zum 15. April 2024	CI

Resolutions of Annual Geneal Meeting	30.04.
Grant of warrants	23.04.
BioPorto Names New Chief Legal Officer	10.04.
BioPorto A/S Appoints Chief Legal Officer	10.04.
Bioporto A/S Appoints Gry Louise Husby Larsen as Chief Legal Officer and Member of the Executive Management Team, Effective as of April 15, 2024	10.04.
New Board Candidate for the upcoming Annual Geneal Meeting	05.04.
Bioporto A/S Announces Tonni Bülow-Nielsennot to Stand for Election	05.04.
Notice convening the Annual General Meeting in BioPorto A/S	04.04.
Correction: BioPorto Announces Annual Results for 2023	04.04.
BioPorto Announces Annual Results for 2023	04.04.
BioPorto A/S Reports Earnings Results for the Full Year Ended December 31, 2023	04.04.
BioPorto Makes Interim CEO Permanent	02.04.
BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer	02.04.
BioPorto A/S Appoints Peter Mørch Eriksen as Permanent Group CEO	02.04.
Bioporto A/S Announces Peter Mørch Eriksen Will Not Stand for Re-Election to the Board of Directors	02.04.
BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026	22.02.
BioPorto A/S Provides Revenue Guidance for the Full Year 2024	22.02.
Roche : collaboration étendue avec le danois BioPorto	20.02.
BioPorto Expands Global Distribution Partnership with Roche Diagnostics	20.02.
Roche Diagnostics and BioPorto expand collaboration	20.02.

Keine Ergebnisse zu dieser Suche